Search research articles
Contact Us
Filters
Showing results (161-170 of 527) with videos related to
Page
of 53
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 9, 2022
Advantage of clinical colchicine concentration to promote sorafenib or regorafenib anti-cancer effects on hepatocellular carcinoma
Zu-Yau Lin, Ming-Lun Yeh, Ching-I Huang, et al.
Scientific Reports
|
October 31, 2015
Amiodarone as an autophagy promoter reduces liver injury and enhances liver regeneration and survival in mice after partial hepatectomy
Chih-Wen Lin, Yaw-Sen Chen, Chih-Che Lin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 6, 2022
Influence of Nonalcoholic Fatty Liver Disease With Increased Liver Enzyme Levels on the Risk of Cirrhosis and Hepatocellular Carcinoma
Yu-Han Huang, Chi Chan, Hye-Won Lee, et al.
Alimentary Pharmacology & Therapeutics
|
October 17, 2023
Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis B
Pin-Nan Cheng, I-Cher Feng, Jyh-Jou Chen, et al.
Hepatology International
|
February 3, 2011
Comparison of adverse effects related to pegylated interferon-based therapy for patients with chronic hepatitis B and chronic hepatitis C in Taiwan
Jeng-Fu Yang, Yi-Hui Kao, Chia-Yen Dai, et al.
Journal of Hepatology
|
February 24, 2009
Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients
Chia-Yen Dai, Jee-Fu Huang, Ming-Yen Hsieh, et al.
Plos One
|
November 6, 2018
Association of hyperuricemia with disease severity in chronic hepatitis C patients
Tyng-Yuan Jang, Ming-Lun Yeh, Ching-I Huang, et al.
Plos One
|
April 4, 2015
Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients
Ming-Lun Yeh, Cheng-Yuan Peng, Chia-Yen Dai, et al.
Japanese Journal of Infectious Diseases
|
February 24, 2006
Prevalence and clinical significance of HGV/GBV-C infection in patients with chronic hepatitis B or C
Jeng-Fu Yang, Chia-Yen Dai, Wan-Long Chuang, et al.
The Journal of Infection
|
July 26, 2005
SEN virus infection among patients on maintenance hemodialysis in southern Taiwan
Chia-Yen Dai, Wan-Long Chuang, Wen-Yu Chang, et al.
Page
of 53
Search research articles
Search
Showing results (161-170 of 527) with videos related to
Sort By:
Page
of 53
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 9, 2022
Advantage of clinical colchicine concentration to promote sorafenib or regorafenib anti-cancer effects on hepatocellular carcinoma
Zu-Yau Lin, Ming-Lun Yeh, Ching-I Huang, et al.
Scientific Reports
|
October 31, 2015
Amiodarone as an autophagy promoter reduces liver injury and enhances liver regeneration and survival in mice after partial hepatectomy
Chih-Wen Lin, Yaw-Sen Chen, Chih-Che Lin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 6, 2022
Influence of Nonalcoholic Fatty Liver Disease With Increased Liver Enzyme Levels on the Risk of Cirrhosis and Hepatocellular Carcinoma
Yu-Han Huang, Chi Chan, Hye-Won Lee, et al.
Alimentary Pharmacology & Therapeutics
|
October 17, 2023
Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis B
Pin-Nan Cheng, I-Cher Feng, Jyh-Jou Chen, et al.
Hepatology International
|
February 3, 2011
Comparison of adverse effects related to pegylated interferon-based therapy for patients with chronic hepatitis B and chronic hepatitis C in Taiwan
Jeng-Fu Yang, Yi-Hui Kao, Chia-Yen Dai, et al.
Journal of Hepatology
|
February 24, 2009
Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients
Chia-Yen Dai, Jee-Fu Huang, Ming-Yen Hsieh, et al.
Plos One
|
November 6, 2018
Association of hyperuricemia with disease severity in chronic hepatitis C patients
Tyng-Yuan Jang, Ming-Lun Yeh, Ching-I Huang, et al.
Plos One
|
April 4, 2015
Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients
Ming-Lun Yeh, Cheng-Yuan Peng, Chia-Yen Dai, et al.
Japanese Journal of Infectious Diseases
|
February 24, 2006
Prevalence and clinical significance of HGV/GBV-C infection in patients with chronic hepatitis B or C
Jeng-Fu Yang, Chia-Yen Dai, Wan-Long Chuang, et al.
The Journal of Infection
|
July 26, 2005
SEN virus infection among patients on maintenance hemodialysis in southern Taiwan
Chia-Yen Dai, Wan-Long Chuang, Wen-Yu Chang, et al.
Page
of 53